Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masafumi Watanabe is active.

Publication


Featured researches published by Masafumi Watanabe.


Pacing and Clinical Electrophysiology | 2018

Biatrial volume, estimated using magnetic resonance imaging, predicts atrial fibrillation recurrence after ablation

Yu Kumagai; Tadateru Iwayama; Takanori Arimoto; Daisuke Kutsuzawa; Naoaki Hashimoto; Harutoshi Tamura; Satoshi Nishiyama; Hiroki Takahashi; Tetsuro Shishido; Sou Yamauchi; Tamon Yamanaka; Takuya Miyamoto; Tetsu Watanabe; Isao Kubota; Masafumi Watanabe

The predictive value of left atrial volume (LAV) in atrial fibrillation (AF) is known, but the relationship of right atrial volume (RAV) and biatrial volume (BAV) with AF recurrence after pulmonary vein isolation (PVI) is not clear. Cardiac magnetic resonance (CMR) imaging allows us to more precisely quantify atrial volume. We investigated LAV, RAV, and BAV as predictors of AF recurrence following PVI in AF patients.


Journal of Clinical Hypertension | 2018

Ventricular wall stress and silent myocardial damage are associated with pulse pressure in the general population

Tetsuya Takahashi; Tetsuro Shishido; Ken Watanabe; Takayuki Sugai; Taku Toshima; Daisuke Kinoshita; Miyuki Yokoyama; Harutoshi Tamura; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Takuya Miyamoto; Tetsu Watanabe; Yoko Shibata; Tsuneo Konta; Yoshiyuki Ueno; Takeo Kato; Takamasa Kayama; Isao Kubota; Masafumi Watanabe

Pulse pressure (PP) is a risk factor for cardiovascular diseases and is associated with increased afterload and myocardial oxygen demand. Brain natriuretic peptide (BNP) and heart‐type fatty acid–binding protein (H‐FABP) are known as biomarkers indicating ventricular wall stress and silent myocardial damage. However, the association between PP and ventricular wall stress and silent myocardial damage in the general population is unclear. The authors enrolled 3504 patients who participated in a community‐based annual health check. Serum levels of BNP and H‐FABP were measured as markers of ventricular wall stress and silent myocardial damage. Patients were divided into four groups according to the quartiles of PP. Patients in the highest PP group showed higher serum BNP and H‐FABP levels than that of the other groups. Multivariate logistic analysis showed that high PP was independently associated with ventricular wall stress and silent myocardial damage on the basis of BNP and H‐FABP levels. Compared with systolic blood pressure, diastolic blood pressure, and mean blood pressure, PP was superior in predicting ventricular wall stress and silent myocardial damage evaluated according to BNP and H‐FABP levels, which was reflected by the receiver operating characteristic analysis. Screening of healthy patients revealed that high PP was related to high BNP and H‐FABP levels, suggesting that an asymptomatic general population with high PP may be exposed to ventricular wall stress and myocardial damage and might be susceptible to silent heart failure.


Heartrhythm Case Reports | 2018

Implantation of a cardiac resynchronization therapy device using the anchor balloon technique in a patient with a tortuous coronary sinus branch

Yu Kumagai; Takanori Arimoto; So Yamauchi; Daisuke Kutsuzawa; Hayato Tsuchiya; Masafumi Watanabe

Cardiac resynchronization results in significant clinical improvement in patients with moderate-to-severe heart failure and an intraventricular conduction delay.1 However, the ability to place stable pacing leads in the coronary sinus tributaries for left ventricular (LV) pacing remains a major limiting factor. The implanting electrophysiologist usually is challenged by a high degree of variability in the coronary venous anatomy.2 We describe a case of successful delivery of the LV lead to the distal region of a tortuous lateral vein using the anchor balloon technique.


Heart and Vessels | 2018

Increased plasma xanthine oxidoreductase activity deteriorates coronary artery spasm

Ken Watanabe; Tetsuro Shishido; Yoichiro Otaki; Tetsu Watanabe; Takayuki Sugai; Taku Toshima; Tetsuya Takahashi; Miyuki Yokoyama; Daisuke Kinoshita; Takayo Murase; Takashi Nakamura; Masahiro Wanezaki; Harutoshi Tamura; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; So Yamauchi; Tamon Yamanaka; Takuya Miyamoto; Isao Kubota; Masafumi Watanabe

Increased reactive oxygen species (ROS) contributes to the development of endothelial dysfunction, which is involved in coronary artery spasm (CAS). Xanthine oxidoreductase (XOR) plays a pivotal role in producing both uric acid and ROS. However, the association between plasma XOR activity and CAS has not been elucidated. The aim of this study was to investigate whether plasma XOR activity is associated with CAS. We measured XOR activity in 104 patients suspected for CAS, who presented without significant coronary artery stenosis and underwent intracoronary acetylcholine provocation tests. CAS was provoked in 44 patients and they had significantly higher XOR activity as compared with those without CAS. The patients were divided into three groups based on the XOR activity. The prevalence rate of CAS was increased with increasing XOR activity. A multivariate logistic regression analysis showed that the 3rd tertile group exhibited a higher incidence of CAS as compared with the 1st tertile group [odds ratio (OR) 6.9, Pu2009=u20090.001) and the 2nd tertile group (OR 3.2, Pu2009=u20090.033) after adjustment for conventional CAS risk factors, respectively. The C index was significantly improved by the addition of XOR activity to the baseline model based on CAS risk factors. Furthermore, the 3rd tertile group had the highest incidence of severe spasm defined as total obstruction, flow-limiting stenosis, diffuse spasm, multivessel spasm, and/or lethal arrhythmia. This is a first report to elucidate the association of plasma XOR activity with CAS. Increased plasma XOR activity is significantly associated with CAS.


Clinical and Experimental Nephrology | 2018

The association between urinary sodium excretion and blood pressure in a community-based population: the Yamagata (Takahata) study

Sayumi Watanabe; Tsuneo Konta; Kazunobu Ichikawa; Masafumi Watanabe; Kenichi Ishizawa; Yoshiyuki Ueno; Hidetoshi Yamashita; Takamasa Kayama; Isao Kubota

BackgroundThe association between salt intake and blood pressure levels is still inconclusive, and may be influenced by patient characteristics. We thus conducted a community-based cross-sectional study.MethodsThis study included 2297 subjects agedu2009≥u200940xa0years not on antihypertensive medication at the time of a health check-up. We examined the association between blood pressure levels and the estimated amount of 24-h urinary sodium excretion (e24hUNa) stratified by background characteristics. The 24-h urinary excretion levels of sodium and potassium were estimated from Kawasaki’s equation using a spot urine sample.ResultsThe association of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with e24hUNa was significantly positive in a multiple linear regression model adjusted for confounders including age, sex, smoking, alcohol consumption, body mass index, diabetes, hypercholesterolemia, renal function, and potassium excretion. The regression coefficients of changes in SBP and DBP per 1 SD increase in e24hUNa (53xa0mEq/day) were +u20091.91xa0mmHg and +u20090.94xa0mmHg, respectively. In the subgroup analyses, the increase in SBP was especially greater in the elderly, in subjects with diabetes, and in subjects with reduced renal function compared to those in the counterparts. The association between SBP and e24hUNa was insignificant in subjects with eGFRu2009≥u200990xa0ml/min/1.73m2, while the association with progression of renal dysfunction was stronger and significant.ConclusionsThese results demonstrated that the association between blood pressure and urinary sodium excretion was strengthened by characteristics of subjects such as aging, presence of diabetes, and renal impairment in the community-based population.


山形大学紀要. 医学 : 山形医学 = Bulletin of the Yamagata University. Medical science : Yamagata medical journal | 2018

The trends in cerebral infarction in Yamagata Prefecture, Japan : A study based on 10 years of stroke registry data

Yuki Yamada; Yasuaki Kokubo; Rei Kondo; Shinya Sato; Takeo Kato; Isao Kubota; Masafumi Watanabe; Takamasa Kayama; Yukihiko Sonoda


Nephrology Dialysis Transplantation | 2018

FP347ATTRIBUTABLE RISK OF CHRONIC KIDNEY DISEASE ON MORTALITY IN A COMMUNITY-BASED POPULATION

Eri Matsuki; Midori Oyama; Soichiro Kon; Akira Araumi; Sayumi Watanabe; Asami Kabasawa; Natsuko Suzuki; Kazunobu Ichikawa; Masafumi Watanabe; Takamasa Kayama; Tsuneo Konta


Nephrology Dialysis Transplantation | 2018

FP350RENAL IMPAIRMENT STRENGTHENS THE EFFECT OF SALT INTAKE ON BLOOD PRESSURE IN A COMMUNITY-BASED POPULATION

Kazunobu Ichikawa; Eri Matsuki; Midori Oyama; Soichiro Kon; Akira Araumi; Sayumi Watanabe; Asami Kabasawa; Natsuko Suzuki; Masafumi Watanabe; Takamasa Kayama; Tsuneo Konta


European Heart Journal | 2018

P6351Direct comparison of prognostic ability of BNP and NT-proBNP for cardiogenic stroke and clinical outcome in patients with stroke

H Tsuchiya; Yoichiro Otaki; Tetsu Watanabe; Gensai Yamaura; Naoto Hashimoto; Masahiro Wanezaki; Harutoshi Tamura; Satoshi Nishiyama; Takanori Arimoto; Hiroki Takahashi; T. Shishido; Isao Kubota; Masafumi Watanabe


European Heart Journal | 2018

P2824Cardiac nuclear high-mobility group box 1 attenuates angiotensin II induced pathological cardiac hypertrophy by inhibiting DNA damage response pathway

Tetsuya Takahashi; T. Shishido; Jun Goto; Ken Watanabe; Takayuki Sugai; Taku Toshima; Tetsu Watanabe; Masafumi Watanabe

Collaboration


Dive into the Masafumi Watanabe's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge